Fate Therapeutics (FATE)
NASDAQ:FATE
Holding FATE?
Track your performance easily

Fate Therapeutics (FATE) Income Statement

1,126 Followers

Fate Therapeutics Income Statement

Last quarter (Q2 2024), Fate Therapeutics's total revenue was $6.77M, an increase of 625.83% from the same quarter last year. In Q2, Fate Therapeutics's net income was $-38.43M. See Fate Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 12.32M$ 63.53M$ 96.30M$ 55.85M$ 31.43M$ 10.68M
Cost of Revenue
------
Gross Profit
$ 12.32M$ 63.53M$ 96.30M$ 55.85M$ 31.43M$ 10.68M
Operating Expense
$ 207.82M$ 254.04M$ 404.69M$ 272.84M$ 159.52M$ 111.41M
Operating Income
$ -195.50M$ -190.51M$ -308.39M$ -216.99M$ -128.09M$ -100.73M
Net Non Operating Interest Income Expense
$ 18.09M$ 17.19M$ 5.84M$ 1.31M$ 2.40M$ 2.58M
Other Income Expense
$ 369.00K$ 12.40M$ 20.82M$ -3.53M$ 47.70M-
Pretax Income
$ -174.17M$ -160.93M$ -281.72M$ -212.15M$ -173.39M$ -98.15M
Tax Provision
$ -4.85M$ -4.85M$ -11.11M$ -6.97M$ -1.30M$ -2.09M
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -175.72M$ -160.93M$ -281.72M$ -212.15M$ -173.39M$ -98.15M
Basic EPS
$ -1.71$ -1.64$ -2.91$ -2.24$ -2.10$ -1.44
Diluted EPS
$ -1.71$ -1.64$ -2.91$ -2.24$ -2.10$ -1.44
Basic Average Shares
$ 415.76M$ 98.41M$ 96.83M$ 94.75M$ 82.39M$ 68.19M
Diluted Average Shares
$ 415.76M$ 98.41M$ 96.83M$ 94.75M$ 82.39M$ 68.19M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 207.82M$ 254.04M$ 404.69M$ 272.84M$ 159.52M$ 111.41M
Net Income From Continuing And Discontinued Operation
$ -175.72M$ -160.93M$ -281.72M$ -212.15M$ -173.39M$ -98.15M
Normalized Income
$ -170.38M$ -165.78M-$ -219.12M--
Interest Expense
------
EBIT
$ -184.39M$ -190.51M$ -308.39M$ -216.99M$ -128.09M$ -96.40M
EBITDA
$ -165.22M$ -172.23M$ -294.63M$ -211.14M$ -125.00M$ -94.56M
Currency in USD

Fate Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis